Morgan Paull

Morgan Paull is an experienced professional in strategy and operations, currently serving as SVP of Strategy and Operations at QED Therapeutics and BridgeBio since November 2021 and March 2020, respectively. Previously held roles include Consultant at McKinsey & Company and Cofounder of Mendo, Inc., a microfluidic liquid-handling company. Earlier experiences include research assistant roles at Harvard School of Public Health and Wyss Institute for Biologically Inspired Engineering, as well as internships in the U.S. Senate and House of Representatives. Morgan completed Master's degrees in Bioengineering and Management Science and Engineering at Stanford University, along with a Bachelor's degree in Engineering Science from Harvard University.